Merit Medical Systems (MMSI) Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MMSI shares.
View MMSI analyst ratings or view top-rated stocks.

6 brokerages have issued 1-year price objectives for Merit Medical Systems' stock. Their MMSI share price forecasts range from $72.00 to $93.00. On average, they anticipate the company's share price to reach $83.43 in the next year. This suggests that the stock has a possible downside of 0.6%.
View analysts price targets for MMSI or view top-rated stocks among Wall Street analysts.

Merit Medical Systems' stock was trading at $70.62 at the beginning of 2023. Since then, MMSI stock has increased by 18.9% and is now trading at $83.95.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our MMSI earnings forecast.

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Wednesday, April, 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.55 by $0.09. The medical instruments supplier had revenue of $297.57 million for the quarter, compared to the consensus estimate of $280.47 million. Merit Medical Systems had a net margin of 7.22% and a trailing twelve-month return on equity of 14.55%. The firm's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.53 earnings per share.

ETFs with the largest weight of Merit Medical Systems (NASDAQ:MMSI) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), Emerge EMPWR Sustainable Select Growth Equity ETF (EMGC), Invesco DWA Healthcare Momentum ETF (PTH), Invesco S&P SmallCap Momentum ETF (XSMO), SPDR S&P Health Care Equipment ETF (XHE), Emerge EMPWR Unified Sustainable Equity ETF (EMPW), SPDR S&P 600 Small Cap Growth ETF (SLYG) and iShares S&P Small-Cap 600 Growth ETF (IJT).

Merit Medical Systems issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided EPS guidance of $2.83-$2.93 for the period, compared to the consensus earnings per share estimate of $2.85. The company issued revenue guidance of $1.22 billion-$1.23 billion, compared to the consensus revenue estimate of $1.20 billion.

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Merit Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (17.57%), William Blair Investment Management LLC (5.91%), ArrowMark Colorado Holdings LLC (5.09%), Conestoga Capital Advisors LLC (3.64%), State Street Corp (3.54%) and Macquarie Group Ltd. (2.44%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, David Floyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra and Ronald Frost.
View institutional ownership trends.

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMSI stock can currently be purchased for approximately $83.95.

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $4.83 billion and generates $1.15 billion in revenue each year. The medical instruments supplier earns $74.52 million in net income (profit) each year or $1.48 on an earnings per share basis.

The company employs 6,846 workers across the globe.

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.